174 related articles for article (PubMed ID: 30359637)
1. Melanoma coexisting with solar elastosis: a potential pitfall in the differential diagnosis between nevus and melanoma.
Konopinski JC; Danialan R; Torres-Cabala CA; Tetzlaff MT; Nagarajan P; Curry JL; Ivan D; Prieto VG; Aung PP
Hum Pathol; 2019 Feb; 84():270-274. PubMed ID: 30359637
[TBL] [Abstract][Full Text] [Related]
2. Solar elastosis and cutaneous melanoma: a site-specific analysis.
Kvaskoff M; Pandeya N; Green AC; Perry S; Baxter C; Davis MB; Mortimore R; Westacott L; Wood D; Triscott J; Williamson R; Whiteman DC
Int J Cancer; 2015 Jun; 136(12):2900-11. PubMed ID: 25403328
[TBL] [Abstract][Full Text] [Related]
3. Displacement of dermal solar elastosis in malignant melanoma.
Horenstein MG; Norton CL; Evans TN
J Cutan Pathol; 2007 May; 34(5):376-80. PubMed ID: 17448191
[TBL] [Abstract][Full Text] [Related]
4. The use of elastin immunostain improves the evaluation of melanomas associated with nevi.
Kamino H; Tam S; Tapia B; Toussaint S
J Cutan Pathol; 2009 Aug; 36(8):845-52. PubMed ID: 19032378
[TBL] [Abstract][Full Text] [Related]
5. Solar elastosis in cutaneous melanoma.
Vollmer RT
Am J Clin Pathol; 2007 Aug; 128(2):260-4. PubMed ID: 17638660
[TBL] [Abstract][Full Text] [Related]
6. Sun exposure and host phenotype as predictors of cutaneous melanoma associated with neval remnants or dermal elastosis.
Lee EY; Williamson R; Watt P; Hughes MC; Green AC; Whiteman DC
Int J Cancer; 2006 Aug; 119(3):636-42. PubMed ID: 16572428
[TBL] [Abstract][Full Text] [Related]
7. Associations of cumulative sun exposure and phenotypic characteristics with histologic solar elastosis.
Thomas NE; Kricker A; From L; Busam K; Millikan RC; Ritchey ME; Armstrong BK; Lee-Taylor J; Marrett LD; Anton-Culver H; Zanetti R; Rosso S; Gallagher RP; Dwyer T; Goumas C; Kanetsky PA; Begg CB; Orlow I; Wilcox H; Paine S; Berwick M;
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2932-41. PubMed ID: 20802019
[TBL] [Abstract][Full Text] [Related]
8. A retrosepctive histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 6. The relation of dermal solar elastosis to sex, age and survival of the patient and to localization, histological type and level of invasion of the tumour.
Larsen TE; Grude TH
Acta Pathol Microbiol Scand A; 1979 Sep; 87A(5):361-6. PubMed ID: 525350
[TBL] [Abstract][Full Text] [Related]
9. Telomerase reverse transcriptase promoter mutations and solar elastosis in cutaneous melanoma.
Lade-Keller J; Yuusufi S; Riber-Hansen R; Steiniche T; Stougaard M
Melanoma Res; 2018 Oct; 28(5):398-409. PubMed ID: 29570169
[TBL] [Abstract][Full Text] [Related]
10. Residual dysplastic and other nevi in superficial spreading melanoma. Clinical correlations and association with sun damage.
Black WC
Cancer; 1988 Jul; 62(1):163-73. PubMed ID: 3383113
[TBL] [Abstract][Full Text] [Related]
11. Etiologic and other factors predicting nevus-associated cutaneous malignant melanoma.
Purdue MP; From L; Armstrong BK; Kricker A; Gallagher RP; McLaughlin JR; Klar NS; Marrett LD;
Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):2015-22. PubMed ID: 16103454
[TBL] [Abstract][Full Text] [Related]
12. The "Umbrella Sign": A Useful Clue in the Diagnosis of Melanocytic Lesions in Sun Damaged Skin.
Wood BA; Harvey NT
Am J Dermatopathol; 2016 Jul; 38(7):504-9. PubMed ID: 26909586
[TBL] [Abstract][Full Text] [Related]
13. Determining the Association Between Melanomas and Fields of Melanocytic Dysplasia.
Mata DA; Lian CG; Hafeez F
Am J Dermatopathol; 2023 Feb; 45(2):90-92. PubMed ID: 36669071
[TBL] [Abstract][Full Text] [Related]
14. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma.
Whiteman DC; Watt P; Purdie DM; Hughes MC; Hayward NK; Green AC
J Natl Cancer Inst; 2003 Jun; 95(11):806-12. PubMed ID: 12783935
[TBL] [Abstract][Full Text] [Related]
15. The role of TERT promoter mutations in differentiating recurrent nevi from recurrent melanomas: A retrospective, case-control study.
Walton KE; Garfield EM; Zhang B; Quan VL; Shi K; Mohan LS; Haugh AM; VandenBoom T; Yazdan P; Isales MC; Panah E; Gerami P
J Am Acad Dermatol; 2019 Mar; 80(3):685-693. PubMed ID: 30287318
[TBL] [Abstract][Full Text] [Related]
16. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
Skender-Kalnenas TM; English DR; Heenan PJ
J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
[TBL] [Abstract][Full Text] [Related]
17. Melanoma in situ versus melanocytic hyperplasia in sun-damaged skin. Assessment of the significance of histopathologic criteria for differential diagnosis.
Weyers W; Bonczkowitz M; Weyers I; Bittinger A; Schill WB
Am J Dermatopathol; 1996 Dec; 18(6):560-6. PubMed ID: 8989926
[TBL] [Abstract][Full Text] [Related]
18. [Rare melanocytes and nevus-cell nevi].
Frenk E; Mevorah B; Delacrétaz J
Hautarzt; 1975 Dec; 26(12):619-24. PubMed ID: 1213881
[TBL] [Abstract][Full Text] [Related]
19. Desmoplastic nevus of chronically sun-damaged skin: an entity to be distinguished from desmoplastic melanoma.
Sidiropoulos M; Sholl LM; Obregon R; Guitart J; Gerami P
Am J Dermatopathol; 2014 Aug; 36(8):629-34. PubMed ID: 25051041
[TBL] [Abstract][Full Text] [Related]
20. Nevus-associated melanomas: clinicopathologic features.
Shitara D; Nascimento MM; Puig S; Yamada S; Enokihara MM; Michalany N; Bagatin E
Am J Clin Pathol; 2014 Oct; 142(4):485-91. PubMed ID: 25239415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
